Logo

After weight loss, regular exercise rather than GLP-1 drug reduces leading cause of heart attacks and strokes

After weight loss, regular exercise rather than GLP-1 drug reduces leading cause of heart attacks and strokes

Maintaining weight loss with regular exercise rather than the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide, a drug used to treat type 2 diabetes and obesity, seems to reduce atherosclerosis development in adults with obesity—a leading underlying cause of cardiovascular disease.

👉 Full Story